Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corp. (NYSE: CGC) shares dipped on Wednesday, following the markets lower after the firm announced that it will purchase a majority stake in a leading producer of sports nutrition products.

Canopy Growth’s Next Steep for Weed Domination

Canopy Growth's agreement with BioSteel is the latest effort by a cannabis company to position itself at the intersection of professional sports and CBD.

Canopy Growth Buys BioSteel Sports Majority Stake; Eyes CBD Drinks For Athletes

Canopy Growth Corporation said Wednesday it has acquired a majority stake in BioSteel Sports Nutrition Inc.

Canopy Growth Enters Sports Nutrition Space, Acquires Majority Stake in BioSteel Sports Nutrition

Cronos Group

An announcement could come as early as next week, sources say.

Report: Ontario Might Abandon Wholesale Cannabis Sales

MedMen Enterprises Inc.

Tilray Brands

A few popular cannabis stocks aren't the bargains they're made out to be.

3 Pot Stocks to Avoid Like the Plague in the Fourth Quarter

Aurora Cannabis

Sector stars Aurora Cannabis, Tilray, and Canopy Growth are scraping the bottom.

Marijuana Stocks Hit 1-Year Lows

Canopy Growth Corp (NYSE: CGC) shares are down nearly 50% in the past six months, but one analyst said Tuesday the company and its patient investors will ultimately be able to ride out the near-term headwinds in the cannabis space.

Analyst: Canopy Growth Can Outlast Near-Term Headwinds

One Wall Street firm thinks this brand-name marijuana stock is worth $6.6 billion less than its own previous forecast.

The Biggest Pot Stock in the World Just Had Its Price Target Slashed by 41%

Addressing the company's mounting losses is going to be a key area of focus for the new boss.

Canopy Growth to Name a New CEO by End of 2019: Will It Be Enough to Turn the Stock Around?

Canopy Growth stock is down from its previous highs, but CGC stock is well-positioned for the next leg of cannabis trends.
The post Canopy Growth Emerges as Top ‘Cannabis 2.0’ Stock appeared first on InvestorPlace.

Canopy Growth Emerges as Top ‘Cannabis 2.0’ Stock

Depending on when you got into Canopy Growth stock, this is either one of your best investments or your worst. However, if you have a longer-term perspective, CGC offers a very compelling narrative.

Does CGC Stock Meet Your Eye Test?

HEXO Corp

The exchange-traded fund also provides access to hemp and CBD stocks.

This Cannabis ETF Gives Investors a New Way to Profit From the Marijuana Market's Torrid Growth

The largest marijuana stock in the world could have at least 20% downside, if not more.

10 Reasons Canopy Growth May Fall Below $20

Bank of America downgrades its recommendation on the shares and makes a deep cut in the price target.

Big Bank Sours on Canopy Growth Stock

Aphria

OrganiGram Holdings Inc.

Here's why a fearless marijuana stock analyst thinks investors are still too optimistic about the next two years.

Will the Big Canadian Pot Producers Miss Expectations Again?

Amplify Alternative Harvest ETF

After a major political win, marijuana stocks face another huge hurdle.

Will the U.S. Senate Deny Cannabis Companies Access to This Vital Service?

Canadian cannabis company Canopy Growth Corp.'s shares CGC, -1.37% WEED, -1.83% slid 1.5% Friday, after Bank of America Merrill Lynch downgraded the stock to neutral from buy and said Wall Street expectations for it are "far too high.

Canopy Growth stock falls as BofA Merrill downgrades and says Street views are 'far too high]

A rough few months for Canopy Growth Corp (NYSE: CGC) investors got even worse on Friday when the stock was hit by a major Wall Street downgrade.

Bank Of America Downgrades Canopy Growth, Projects 26% Revenue Miss

Will Cannabis 2.0 be enough to save CGC? The management of the company believes that it will be a major catalyst for CGC stock
The post Will Cannabis 2.0 Save Canopy Growth Stock?

Will Cannabis 2.0 Save Canopy Growth Stock?

In an industry where issuing stock has become commonplace, cash has lost its luster.

In the Marijuana Industry, Cash Isn't King

After initially recommending investors stay on the sidelines with CGC, evidence is building that they should now consider purchasing shares. 
The post It’s Finally Time to Consider Buying Canopy Growth Stock appeared first on InvestorPlace.

It’s Finally Time to Consider Buying Canopy Growth Stock

A U.S. Senate vote in favor of the SAFE Banking Act that would allow banks to serve cannabis companies without fear of federal enforcement actions would not present a triggering event for Canada's Canopy Growth Corp.

Senate passage of SAFE Banking Act would not be trigger for Canopy/Acreage deal: MKM

Cannabis stocks are in a bear phase and it is taking CGC stock down with it. Beyond next year, profits are around the corner.

CGC Stock Looks Like a Buy on the Dip as Stock Falters on Vape Worries

These pot stocks could soon have investors bubbling over with excitement.

3 Brand-Name Cannabis-Infused Beverage Stocks You Need to Know

Mark Zekulin says a long list of operational improvements and new products will bolster profits and sales.

News for Canopy Growth Stock (CGC)